Lin Xiao-Yan, Cai Feng-Feng, Wang Ming-Hong, Pan Xin, Wang Fang, Cai Lu, Cui Rong-Rong, Chen Su, Biskup Ewelina
Department of Breast Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, P.R. China.
Department of Cardiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, P.R. China.
Oncol Lett. 2017 Nov;14(5):5457-5463. doi: 10.3892/ol.2017.6852. Epub 2017 Aug 28.
Mammalian sterile 20-like kinase 1 (Mst1) is a major inhibitor of cell proliferation, and is involved in apoptosis, oncogenesis and organ growth via its ubiquitously encoded serine threonine kinase. Previous studies have demonstrated that Mst1 has a tumor suppressor function in human breast cancer. Mst1 deletion or mutation is associated with tumorigenesis, whereas Mst1 overexpression leads to tumor cell apoptosis and decreases proliferation of tumor cells. Our previous study reported the tumor suppressive function of Mst1, and debated Mst1 as a prognostic factor in human breast cancer. In the present study, Mst1 levels were measured in the plasma of patients in order to elucidate their association with overall and disease-free survival. The results of the present study indicated that Mst1 is a strong prognostic and predictive factor in human breast cancer and a promising anticancer target.
哺乳动物不育 20 样激酶 1(Mst1)是细胞增殖的主要抑制剂,通过其普遍编码的丝氨酸苏氨酸激酶参与细胞凋亡、肿瘤发生和器官生长。先前的研究表明,Mst1 在人类乳腺癌中具有肿瘤抑制功能。Mst1 的缺失或突变与肿瘤发生相关,而 Mst1 的过表达导致肿瘤细胞凋亡并降低肿瘤细胞的增殖。我们之前的研究报道了 Mst1 的肿瘤抑制功能,并将 Mst1 作为人类乳腺癌的一个预后因素进行了讨论。在本研究中,检测了患者血浆中的 Mst1 水平,以阐明其与总生存期和无病生存期的关系。本研究结果表明,Mst1 是人类乳腺癌中一个强有力的预后和预测因素,也是一个有前景的抗癌靶点。